Oncology & Cancer

Study finds cancer patients do benefit from COVID-19 vaccination

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...

Gastroenterology

How probiotic bacteria benefit the intestine

Interaction between the gut microbiota and the immune system is important for host physiology and susceptibility to disease, but also for the efficacy of e.g., cancer immunotherapies. A multidisciplinary research team have ...

Immunology

New findings on B cells may improve vaccine design

Our bodies can fine-tune the immune response to an infection and make it proportional to the threat at hand. New research from Karolinska Institutet in Sweden describes how B lymphocytes, the immune cells that make antibodies, ...

Diseases, Conditions, Syndromes

Genetics may play role in determining immunity to COVID-19

Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting concerns about the prospects of long-lasting immunity and efficacy of COVID-19 ...

page 1 from 7